Sergei Andreevich Ageev

Title: The Innovations of Sergei Andreevich Ageev

Introduction

Sergei Andreevich Ageev is a notable inventor based in Chehov, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents is a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology and focuses on antibodies or antigen-binding fragments, as well as their applications. The patent details a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody, which can be used in treating diseases associated with GITR. Another significant patent is for a monoclonal antibody to PD-L1. This invention also pertains to biotechnology and provides antibodies that specifically bind to PD-L1, along with DNA encoding these antibodies and methods of production and treatment.

Career Highlights

Throughout his career, Sergei Ageev has demonstrated a commitment to advancing biotechnological research. His innovative approaches to antibody development have positioned him as a key figure in his field.

Collaborations

Sergei has collaborated with notable colleagues, including Andrei Borisovich Ulitin and Valery Vladimirovich Solovyev. These partnerships have likely contributed to the success of his research and patent applications.

Conclusion

In summary, Sergei Andreevich Ageev is a prominent inventor in the biotechnology sector, with a focus on monoclonal antibodies. His patents reflect his dedication to improving medical treatments through innovative research.